NEW YORK (Reuters Health)—The interleukin 23 inhibitor guselkumab is associated with more improvement in psoriasis on the scalp, palms and/or soles compared with adalimumab, a new analysis suggests. Andrew Blauvelt, MD, MBA, of Oregon Medical Research Center in Portland conducted a secondary analysis of data from the international VOYAGE 1 and VOYAGE 2 studies, double-blind,…
Search results for: health insurance
ACR/ARHP Members Call on Congress to Restore Patients’ Voices
WASHINGTON, D.C.—The ACR hosted the 2018 Advocacy Leadership Conference in Washington, D.C., on May 16–17. Rheumatology professionals from around the country flew to our nation’s capitol to attend the conference, where advocates heard from key policymakers and spoke with lawmakers about the issues that affect the rheumatology community—and what ACR/ARHP members can do to influence policy….
Affiliate Society Council Meeting Provides Motivation, Fellowship, Opportunity
On Wednesday, May 16, 2018, the ACR’s Affiliate Society Council (ASC) convened a meeting in Washington, D.C., in conjunction with the ACR’s Advocacy Leadership Conference. Despite inclement weather that delayed or cancelled numerous flights, several rheumatology representatives from states across the U.S. attended the meeting in person, while others participated by conference call. “It was…
3 Ways to Improve How You Work with Doctors from Other Specialties
Many trainees tell me they’re attracted to rheumatology because it demands becoming a complete physician. We need knowledge of the brain, eye, lung, kidney, liver, skin, bones and vascular system to be effective rheumatologists. And because our diseases are frequently multisystem diseases, rheumatologists must be the quintessential collaborators. For more than 30 years, I’ve directed…
Generic-Drug Price Fixing: Is It Happening?
It started with an inhaler. Like many of you, I am a rheumatologist. And like you, I see some patients more often their own primary care provider. This is so often the case that I have gradually devolved into their backup, all-purpose doctor. I am the doc they notify when they get hospitalized for pneumonia…
ACR/ARHP Heads to D.C. for Advocacy Leadership Conference
ACR/ARHP leaders are once again heading to Washington, D.C., to advocate for legislation important to rheumatologists and their patients. On May 16–18, more than 100 representatives of the ACR Board of Directors, Executive Committee, Government Affairs Committee, RheumPAC, Committee on Rheumatologic Care, Insurance Subcommittee and Affiliate Society Council and others will talk to members of…
Protecting Patient Care on All Fronts: A Conversation with Kent “Kwas” Huston, MD, ACR Government Affairs Committee Member
Kent “Kwas” Huston, MD, remembers the conversations he had with his father’s rheumatology patients in Kansas City, Mo., when he visited his father’s practice while he was growing up. “They shared what a difference he made for them,” Dr. Huston explains. Dr. Huston also saw firsthand the importance of rheumatology care. His mother was diagnosed…
A Guide to Understanding Physician Compensation Models
Understanding your compensation is critical before you decide to accept a job. In the world of medical practices or groups, however, this understanding is even more essential, because a wide variety of compensation structures for physicians exists. These compensation models can dictate not only what a physician will make in the near future, but also…
Patient Satisfaction Scores—Do They Matter?
You see a patient for the first time to establish care for Sjögren’s disease. She complains of dry eyes, dry mouth and diffuse arthralgias. You do not appreciate any synovitis on physical exam. Of note, you are the fourth rheumatologist she has seen during the past year. Toward the end of the clinic visit, she…
CVS Rolls Out New Tool to Combat Rising Drug Prices
(Reuters)—Drugstore chain CVS Health Corp on Wednesday launched a new tool that will allow pharmacies help customers tackle the soaring cost of drugs by comparing prices of medicines. U.S. healthcare companies, ranging from insurers to drug retailers, are stepping up efforts to combat rising drug prices that has been widely criticized by regulators and has…
- « Previous Page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- …
- 113
- Next Page »